38 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... Pneumocystis pneumonia (PCP ... Mycobacterium tuberculosis ... HIVAIDS #IDSA #management ... #pharmacology
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • Pulmonary ... count <50 • Pulmonary ... Antiretroviral #Therapy ... #Infections #management
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
antiretroviral therapy ... antiretroviral therapy ... antimicrobial therapy ... 80% sensitive Tuberculous ... - Hemorrhage, tuberculomas
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in Tuberculosis ... Diagnosis and Management ... symptoms of active pulmonary ... for concomitant pulmonary ... intensive RIPE therapy
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - ... ActiveTB #RIPE #Therapy ... #medications #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Recent infection • Pulmonary ... • HIV: 2/3 pulmonary ... destruction (including pulmonary ... staining, NAA (PCR ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Recent infection • Pulmonary ... • HIV: 2/3 pulmonary ... destruction (including pulmonary ... staining, NAA (PCR ... TB #Diagnosis #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
areas Preferred Therapy ... Patients Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Chronic Maintenance Therapy ... mm3 Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology